Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58


Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.

Malstrom S, Tili E, Kappes D, Ceci JD, Tsichlis PN.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14967-72.


Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.

Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Möröy T.

Oncogene. 1999 Dec 16;18(54):7816-24.


Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.

Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, Thompson A, Hendley J, Germain D.

Oncogene. 2003 Jul 10;22(28):4425-33.


The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

van Dyk LF, Hess JL, Katz JD, Jacoby M, Speck SH, Virgin HW IV.

J Virol. 1999 Jun;73(6):5110-22.


Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.

Zimmet JM, Toselli P, Ravid K.

Stem Cells. 1998;16 Suppl 2:97-106.


The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo.

Bryja V, Pacherník J, Faldíková L, Krejcí P, Pogue R, Nevrivá I, Dvorák P, Hampl A.

Biochim Biophys Acta. 2004 May 3;1691(2-3):105-16.


Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.

Geisen C, Karsunky H, Yücel R, Möröy T.

Oncogene. 2003 Mar 20;22(11):1724-9.


p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.

Cheng N, van de Wetering CI, Knudson CM.

PLoS One. 2008 Apr 2;3(4):e1911. doi: 10.1371/journal.pone.0001911.


Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest.

Mullany LK, Nelsen CJ, Hanse EA, Goggin MM, Anttila CK, Peterson M, Bitterman PB, Raghavan A, Crary GS, Albrecht JH.

J Biol Chem. 2007 Jul 20;282(29):21244-52. Epub 2007 May 21.


H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression.

Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, Mann DJ, Lam EW.

J Biol Chem. 2002 Apr 19;277(16):13761-70. Epub 2002 Feb 4.


Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Preclíková H, Bryja V, Pacherník J, Krejcí P, Dvorák P, Hampl A.

Cell Growth Differ. 2002 Sep;13(9):421-30.


Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.

Paternot S, Coulonval K, Dumont JE, Roger PP.

J Biol Chem. 2003 Jul 18;278(29):26533-40. Epub 2003 Apr 30.


The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.

Zaldumbide A, Carlotti F, Pognonec P, Boulukos KE.

J Immunol. 2002 Nov 1;169(9):4873-81.


Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, Sicinski P.

Cancer Cell. 2003 Dec;4(6):451-61.


Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.

Sasaki E, Yatabe Y, Hashimoto M, Yamashita Y, Hasegawa Y, Kojima H, Nagasawa T, Mori N.

Pathol Int. 2007 Feb;57(2):53-9.


Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.

Rodriguez-Puebla ML, LaCava M, Miliani De Marval PL, Jorcano JL, Richie ER, Conti CJ.

Am J Pathol. 2000 Sep;157(3):1039-50.


Cyclin D3 expression in normal fetal, normal adult and neoplastic feline tissue.

Norris AJ, Griffey SM, Lucroy MD, Madewell BR.

J Comp Pathol. 2005 May;132(4):329-39. Epub 2005 Apr 18.


Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice.

Mataraza JM, Tumang JR, Gumina MR, Gurdak SM, Rothstein TL, Chiles TC.

J Immunol. 2006 Jul 15;177(2):787-95.

Items per page

Supplemental Content

Write to the Help Desk